Aeluma, Inc.
16.01+0.04 (+0.25%)
Oct 29, 4:00:01 PM EDT · NasdaqCM · ALMU · USD
Key Stats
Market Cap
285.81MP/E (TTM)
-Basic EPS (TTM)
-0.23Dividend Yield
0%Recent Filings
8-K
Aeluma unveils investor update
Aeluma disclosed its October 2025 investor presentation, highlighting FY2025 revenue of $4.7M, up from $0.9M last year, fueled by six R&D contracts and 20 active customer engagements. The company boasts a debt-free balance sheet with $39.2M in pro-forma cash as of June 30, positioning it to scale InGaAs semiconductor tech for defense, AI, and automotive markets. Breakthroughs enable 12-inch wafer production, slashing costs 10X versus incumbents. Forward-looking priorities target new contracts and team expansion amid U.S. semiconductor resurgence.
10-K
FY2025 results
Aeluma's FY2025 revenue surged 407.9% y/y to $4.7 million, driven by $4.4 million from government contracts including a $11.7 million DARPA award, while commercial sales added $266 thousand; this marked a sharp acceleration from FY2024's $919 thousand, with Q4 momentum fueled by Navy and DOE deals closing the year. Operating expenses rose 24.2% to $6.8 million amid higher R&D and materials costs, yielding a narrowed net loss of $3.0 million (down 33.8% y/y) and $0.23 diluted EPS on 13.2 million shares. Cash swelled to $15.7 million post-$12.6 million IPO net proceeds, bolstering $16.6 million working capital for scaling; no dividends or buybacks occurred. Remaining obligations hit $10.2 million, but customer concentration—71% from one government client—poses risks to quarterly flows.
8-K
Aeluma's revenue surges
Aeluma reported fiscal Q4 2025 revenue of $1.3 million, up sharply from $279 thousand last year, driven by R&D contracts with NASA, U.S. Navy, and Department of Energy. Full-year revenue hit $4.7 million, slashing GAAP net loss to $3.0 million from $4.6 million, bolstered by $15.7 million cash and no debt. Momentum builds. Fiscal 2026 guidance eyes $4.0-$6.0 million revenue amid new contracts and team expansion, yet forward-looking risks loom from market uncertainties.
8-K
Aeluma names new CFO
Aeluma appointed Christopher Stewart as full-time CFO effective August 4, 2025, replacing interim officer James Seo. Stewart, with over 20 years in tech finance including stints at LeddarTech and Bionano Genomics, will earn $300,000 annually plus 110,000 stock options and 55,000 RSUs. This bolsters financial leadership amid commercialization push. His expertise sharpens capital navigation.
10-Q
Q3 FY2025 results
Aeluma swung to a Q3 profit of $1.5M, or $0.11 diluted EPS, on revenue that rocketed 265% y/y to $1.3M from government contracts, while operating loss narrowed 14% y/y to $0.8M amid higher G&A from stock comp. YTD revenue climbed 424% y/y to $3.3M, yet net loss widened to $2.2M from $3.6M last year, driven by $0.7M non-cash amortization on convertible notes and $0.3M fair-value changes—net differing from operating by over 20% due to those items. Cash swelled to $15.9M post a $12.6M public offering in March 2025 and $3.1M note conversion, yielding negative FCF of $1.2M (derived) but ample runway. No debt lingers. Remaining obligations hit $9.4M on fresh awards. Customer concentration runs high.
ALAB
Astera Labs, Inc.
173.62+5.37
ALGM
Allegro MicroSystems, Inc.
30.74+0.08
AMBA
Ambarella, Inc.
86.00-0.30
AOSL
Alpha and Omega Semiconductor L
28.69-1.05
LAZR
Luminar Technologies, Inc.
2.09+0.03
LITE
Lumentum Holdings Inc.
214.28+15.89
POET
POET Technologies Inc.
6.63-0.44
SELX
Semilux International Ltd.
0.81+0.08
TSM
Taiwan Semiconductor Manufactur
305.09+3.56
UMC
United Microelectronics Corpora
7.39-0.24